INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
2.330
+0.150 (6.88%)
At close: Sep 18, 2026, 4:00 PM EDT
2.341
+0.011 (0.46%)
After-hours: Sep 18, 2026, 7:30 PM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $64.67 million as of September 18, 2026. Its market cap has increased by 27.35% in one year.
Market Cap
64.67M
Enterprise Value
47.66M
1-Year Change
27.35%
Ranking
Category
Stock Price
$2.33
ChartMarket Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $64.67M, a decrease of -16.91%. That is a compound annual growth rate of -2.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 64.67M | 55.92% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pliant Therapeutics | 68.73M |
| XBiotech | 66.77M |
| Alps Group | 66.56M |
| Spero Therapeutics | 65.81M |
| Gossamer Bio | 65.57M |
| LeonaBio | 63.97M |
| Boundless Bio | 63.92M |
| MindWalk Holdings | 63.90M |